These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15565256)

  • 21. The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections-A Systematic Review of the Literature.
    Kizny Gordon AE; Mathers AJ; Cheong EYL; Gottlieb T; Kotay S; Walker AS; Peto TEA; Crook DW; Stoesser N
    Clin Infect Dis; 2017 May; 64(10):1435-1444. PubMed ID: 28200000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil.
    Scheffer MC; Bazzo ML; Steindel M; Darini AL; Clímaco E; Dalla-Costa LM
    Rev Soc Bras Med Trop; 2010; 43(4):367-71. PubMed ID: 20802932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit.
    Talon D; Capellier G; Boillot A; Michel-Briand Y
    Intensive Care Med; 1995 Dec; 21(12):996-1002. PubMed ID: 8750124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping.
    Silva FM; Carmo MS; Silbert S; Gales AC
    Microb Drug Resist; 2011 Jun; 17(2):215-20. PubMed ID: 21332364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
    Doi Y; Ghilardi AC; Adams J; de Oliveira Garcia D; Paterson DL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3388-90. PubMed ID: 17576840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
    Tran-Dinh A; Neulier C; Amara M; Nebot N; Troché G; Breton N; Zuber B; Cavelot S; Pangon B; Bedos JP; Merrer J; Grimaldi D
    J Hosp Infect; 2018 Nov; 100(3):e105-e114. PubMed ID: 29857026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland.
    Brzozowski M; Krukowska Ż; Galant K; Jursa-Kulesza J; Kosik-Bogacka D
    BMC Infect Dis; 2020 Sep; 20(1):693. PubMed ID: 32962640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore.
    Koh TH; Wang GC; Sng LH
    J Clin Microbiol; 2004 Nov; 42(11):5378-80. PubMed ID: 15528748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
    Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region].
    Kuwabara M; Kusano N; Shimizu E; Shimizu W; Kobayashi K; Koda S; Doi M; Sugai M; Kumon H
    Jpn J Antibiot; 2011 Apr; 64(2):97-108. PubMed ID: 21721248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Gales AC; Menezes LC; Silbert S; Sader HS
    J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
    Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy.
    Horii T; Muramatsu H; Morita M; Maekawa M
    Microb Drug Resist; 2003; 9(2):223-9. PubMed ID: 12820809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
    Durojaiye OC; Carbarns N; Murray S; Majumdar S
    J Hosp Infect; 2011 Jun; 78(2):154-5. PubMed ID: 21507523
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.